Citation: Rm. Bremnes et al., PACLITAXEL IN COMBINATION WITH CISPLATIN, ETOPOSIDE AND THORACIC RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC) - A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 497-497
Citation: T. Risberg et al., PATIENTS OPINION AND USE OF NON-PROVEN THERAPIES RELATED TO THEIR VIEW ON CANCER ETIOLOGY, Anticancer research, 18(1B), 1998, pp. 499-505
Authors:
RISBERG T
BREMNES RM
WIST E
KAASA S
JACOBSEN BK
Citation: T. Risberg et al., COMMUNICATING WITH AND TREATING CANCER-PATIENTS - HOW DOES THE USE OFNON-PROVEN THERAPIES AND PATIENTS FEELING OF MENTAL DISTRESS INFLUENCE THE INTERACTION BETWEEN THE PATIENT AND THE HOSPITAL STAFF, European journal of cancer, 33(6), 1997, pp. 883-890
Authors:
SMELAND E
FUSKEVAG OM
NYMANN K
SVENDSEN JS
OLSEN R
LINDAL S
BREMNES RM
AARBAKKE J
Citation: E. Smeland et al., HIGH-DOSE 7-HYDROXYMETHOTREXATE - ACUTE TOXICITY AND LETHALITY IN A RAT MODEL, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 415-422
Citation: Rm. Bremnes et al., RADIOTHERAPY IN THE TREATMENT OF SYMPTOMATIC VERTEBRAL HEMANGIOMAS - TECHNICAL CASE-REPORT, Neurosurgery, 39(5), 1996, pp. 1054-1058
Citation: Rm. Bremnes et E. Wist, DO PATIENTS ATTITUDES TO CANCER-CHEMOTHERAPY DIFFER FROM THAT OF DOCTORS, NURSES, AND THE GENERAL PUBLIC, European journal of cancer, 31A, 1995, pp. 282-282
Citation: Rm. Bremnes et al., CANCER-PATIENTS, DOCTORS AND NURSES VARY IN THEIR WILLINGNESS TO UNDERTAKE CANCER-CHEMOTHERAPY, European journal of cancer, 31A(12), 1995, pp. 1955-1959
Authors:
SMELAND E
BREMNES RM
FUSKEVAG OM
AARBAKKE J
Citation: E. Smeland et al., THE EFFECT OF CALCIUM-CHANNEL BLOCKERS AND CALCIUM ON METHOTREXATE ACCUMULATION IN RAT HEPATOCYTES, Anticancer research, 15(4), 1995, pp. 1221-1225
Authors:
SMELAND E
BREMNES RM
FUSKEVAG OM
AARBAKKE J
Citation: E. Smeland et al., PERTURBATION OF METHOTREXATE TRANSPORT BY VERAPAMIL, VINBLASTINE, TAUROCHOLATE AND BROMOSULFOPHTHALEIN IN RAT HEPATOCYTES, Anticancer research, 15(1), 1995, pp. 45-50
Citation: J. Norum et al., THE CH1VPP REGIMEN, A RISK FACTOR FOR HERPES-ZOSTER VIRUS-INFECTION IN PATIENTS TREATED FOR HODGKINS-DISEASE, European journal of haematology, 53(1), 1994, pp. 51-53
Authors:
SMELAND E
BREMNES RM
ANDERSEN A
JAEGER R
EIDE TJ
HUSEBY NE
AARBAKKE J
Citation: E. Smeland et al., RENAL AND HEPATIC TOXICITY AFTER HIGH-DOSE 7-HYDROXYMETHOTREXATE IN THE RAT, Cancer chemotherapy and pharmacology, 34(2), 1994, pp. 119-124
Authors:
AASEBO U
BREMNES RM
DEJONG FH
AAKVAAG A
SLORDAL L
Citation: U. Aasebo et al., PITUITARY-GONADAL DYSFUNCTION IN MALE-PATIENTS WITH LUNG-CANCER - ASSOCIATION WITH SERUM INHIBIN LEVELS, Acta oncologica, 33(2), 1994, pp. 177-180
Authors:
AASEBO U
GYLTNES A
BREMNES RM
AAKVAAG A
SLORDAL L
Citation: U. Aasebo et al., REVERSAL OF SEXUAL IMPOTENCE IN MALE-PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE AND HYPOXEMIA WITH LONG-TERM OXYGEN-THERAPY, Journal of steroid biochemistry and molecular biology, 46(6), 1993, pp. 799-803
Authors:
SMELAND E
BREMNES RM
BESSESEN A
JAEGER R
AARBAKKE J
Citation: E. Smeland et al., INTERACTIONS OF VINBLASTINE AND VINCRISTINE WITH METHOTREXATE TRANSPORT IN ISOLATED RAT HEPATOCYTES, Cancer chemotherapy and pharmacology, 32(3), 1993, pp. 209-214